← Back to All Filings

Vanguard Reports 0% Stake in Elevance Health Due to Internal Realignment

Low SignificanceMarch 26, 2026 at 6:04:59 PM EDT

Elevance Health, Inc.

$ELVSCHEDULE 13G/ACIK: 0001156039

Subscribe to track ELV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Reports 0% Stake in Elevance Health Due to Internal Realignment

Company: Elevance Health, Inc. Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Investor: The Vanguard Group Type: Institutional Investor

Filing Details: • Shares Owned: 0 • Percent of Class: 0% • Reason: Internal corporate realignment

Key Insight: Vanguard Group Inc. reports 0 shares due to an internal realignment where subsidiaries now report ownership separately. This does not necessarily indicate a sale of the underlying assets, but a change in the reporting entity structure.

Market Context: Elevance Health has a market cap of $64.33B. This filing is technical in nature.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Elevance Health, Inc.

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an internal administrative realignment, not a market disposition.
  • Market Impact: Neutral; this is a technical reporting change rather than a signal of bearish sentiment.

Company Information

FieldValue
CompanyElevance Health, Inc.
CIK0001156039
IndustryHospital & Medical Service Plans
Market Cap$64.33 Billion
Shares Outstanding220,700,000

Insider/Investor Information

FieldValue
NameThe Vanguard Group
CIK0000102909
TypeInstitutional Investor
LocationMalvern, PA

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Event Date03/13/2026
Shares Owned After0
Percent of Class0%
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

MetricValue
Post-Transaction Ownership0 shares (0% of outstanding)
Materiality AssessmentLow (Administrative)

Impact Evaluation

  • Market Cap Context: With a market cap of $64.33 billion, Vanguard is a major institutional player. However, this filing represents a change in who reports the shares, not necessarily a liquidation of the position.
  • Ownership Concentration: The filing indicates that Vanguard Group Inc. itself no longer holds the reportable interest, passing reporting duties to subsidiaries.
  • Transaction Significance: While the reduction to 0% appears drastic numerically, the explanatory note clarifies it is a legal restructuring.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing contains a specific footnote explaining that Vanguard Group, Inc. underwent an internal realignment on January 12, 2026. Subsidiaries will now report beneficial ownership separately. Investors should not interpret this as a sell-off.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Realignment Details: The filing states: "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately... The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries."
  • Regulatory Basis: The change is made in reliance on SEC Release No. 34-39538.
Topics:#ElevanceHealth#Vanguard#SECFiling#Schedule13G#InstitutionalOwnership#MarketNews#StockMarket#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.